| Financial Year |
March 31 2023 |
| Monetary Funds |
384,510,525.16 |
| Held-for-trading Financial Assets |
70,398,000.00 |
| Notes Receivable |
25,576,119.01 |
| Accounts Receivable |
391,247,081.26 |
| Advances to Suppliers |
30,971,525.65 |
| Other Receivables |
2,967,841.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,146,591.74 |
| Dividend Receivable |
-- |
| Inventories |
145,177,064.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,996,256.04 |
| Total Current Assets |
1,204,716,259.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
484,453,593.70 |
| Under-construction Projects |
37,109,659.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
119,656,042.23 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,970,043.80 |
| Deferred Income Tax Assets |
14,096,753.55 |
| Other Non-Current Assets |
11,423,446.53 |
| Sub-Total of Non-Current Assets |
677,709,538.89 |
| Total Assets |
1,882,425,798.58 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
204,469.40 |
| Notes Payable |
335,313,934.51 |
| Accounts Payable |
146,854,324.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,383,633.37 |
| Taxes Payable |
7,175,027.56 |
| Interest Payable |
-- |
| Dividend Payable |
500.00 |
| Other payables |
21,462,547.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
529,631.62 |
| Sub-Total of Current Liabilities |
524,456,406.44 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,401,359.31 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,796,257.59 |
| Total Liabilities |
544,252,664.03 |
| Paid-In Capital(Or Share Stock) |
183,860,000.00 |
| Capital Surplus |
765,846,769.07 |
| Surplus Reserve |
23,250,910.42 |
| LESS:Treasury Stock |
19,520,050.00 |
| Undistributed Profits |
373,099,940.99 |
| Minority Stockholder's Interest |
11,635,564.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,326,537,570.48 |
| Owner's Equity（Stockholder's Equity） |
1,338,173,134.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,882,425,798.58 |
